Citations 1
BRUIN MCL-321: Phase III Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in BTK Inhibitor Naive Mantle Cell Lymphoma
Eyre, Toby A. , Shah, Nirav N. , Dreyling, Martin , Jurczak, Wojciech , Gandhi, Mitul, Chay, Christopher H., Sharman, Jeff P. , Andorsky, David , Messersmith, Hannah M, Ruppert, Amy S. , Muthig, Valerie A., Ito, Rodrigo, Wang, Michael , Jurczak, Wojciech , Wang, Yucai , Cheah, Chan Y. , Song, Yuqin , Muthig, Valerie
Future Oncology | November 15, 2022 | Volume: 18 | Issue: 36 | Pages: 3961-3969
